Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis.

Christos-Georgios KontovazainitisDimitra GialamprinouGeorgios N KatsarasAbraham PouliakisTheodoros TheodoridisGeorgios Mitsiakos

Published in: American journal of perinatology (2022)

· Combined therapy is not superior to aspirin alone.. · Combined therapy in women with thrombophilia may protect against early-onset preeclampsia.. · Combined therapy in moderate/high-risk women may protect against SGA <10th percentile neonates..

Keyphrases

early onset
gestational age
late onset
low dose
atrial fibrillation
pregnancy outcomes
birth weight
venous thromboembolism
cardiovascular disease
stem cells
polycystic ovary syndrome
coronary artery disease
mesenchymal stem cells
pregnant women
skeletal muscle
replacement therapy